SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-004059
Filing Date
2021-01-25
Accepted
2021-01-25 16:30:11
Documents
3
Period of Report
2021-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea133854-8k_aikidopharma.htm 8-K 20069
2 PRESS RELEASE, DATED JANUARY 22, 2021 ea133854ex99-1_aikidopharma.htm EX-99.1 7776
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10738
  Complete submission text file 0001213900-21-004059.txt   44149
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
AIkido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 21549936
SIC: 8731 Services-Commercial Physical & Biological Research